GE HealthCare Global Private Limited is a healthcare technology company providing integrated precision care solutions across imaging, ultrasound, patient care systems, and pharmaceutical diagnostics. Spun off from General Electric on January 4, 2023, the company now operates as an independent public entity traded on Nasdaq, serving over 1 billion patients annually across 160+ countries with a global workforce of approximately 54,000 colleagues.
The company operates substantial technical infrastructure supporting medical device ecosystems and healthcare delivery. Its imaging segment powers more than 200 software applications, whilst its installed base exceeds 5 million pieces of equipment deployed across hospitals and diagnostic facilities worldwide. GE HealthCare has granted over 11,000 patents globally and invests more than $5.1 billion annually in research and product development, reflecting the capital intensity of healthcare technology innovation.
As a data-intensive enterprise, GE HealthCare processes and manages information flows across medical imaging systems, diagnostic platforms, and patient care solutions deployed at scale. The company's technology stack encompasses AI-powered healthcare software, intelligent medical devices, and care delivery systems that operate across diverse geographic and infrastructure contexts, from remote regions to major medical centres. This operational scope creates substantial requirements for data architecture, processing, and systems management across distributed global installations.
